| NYHA | New York Heart Association Heart Disease에 대한 Functional Classification &nbs... |
|---|---|
| WDMF | wall-defective microbial forms |
| CEA | Carcino-Embryonic Antigen [HP 1825-6] ; Oncofetal Antigens ; Glycopro... |
| HIVD | Herniation(Herniated) of Inter-Vertebral Disc - Cervical HIVD &... |
| PEEP | Positive End-Expiratory Pressure ? Ix 1. PaO2 < 60 mmHg, ... |
| DRO | Differential Reinforcement of Other Behaviour |
|---|---|
| MOTT | Mycobacteria Other Than Tuberculosis |
| OND | Other Neurological Diseases |
| SO | significant other |
| AOD | and other drug |
| cryptococcosis | An acute, subacute or chronic infection by the fungal organism, Cryptococcus neoformans. Infection generally causes a pulmonary infection but may also disseminate to the meninges. The pulmonary form is generally mild and transient (often unrecognised). With dissemination lesions may occur in the skeletal, cutaneus and visceral tissues. The most commonly recognised dissemination is to the central nervous system (meningitis). (27 Sep 1997) |
|---|---|
| other-directed | Pertaining to a person readily influenced by the attitudes of others. (05 Mar 2000) |
| transferases (other substituted phosphate groups) | <enzyme> A class of enzymes that transfers substituted phosphate groups. Registry number: EC 2.7.8 (12 Dec 1998) |
| accole forms | A term applied to the manner in which the ring stage of Plasmodium falciparum parasitises the marginal portion of erythrocytes. Synonym: accole forms. (05 Mar 2000) |
| applique forms | A term applied to the manner in which the ring stage of Plasmodium falciparum parasitises the marginal portion of erythrocytes. Synonym: accole forms. (05 Mar 2000) |
| atypical bacterial forms | Microorganisms that have undergone greater changes than normal in morphology, physiology, or cultural characteristics. (12 Dec 1998) |
| dosage forms | Completed forms of the pharmaceutical preparation in which prescribed doses of medication are included. They are designed to resist action by gastric fluids, prevent vomiting and nausea, reduce or alleviate the undesirable taste and smells associated with oral administration, achieve a high concentration of drug at target site, or produce a delayed or long-acting drug effect. They include capsules, liniments, ointments, pharmaceutical solutions, powders, tablets, etc. (12 Dec 1998) |
| forms and records control | A management function in which standards and guidelines are developed for the developing, maintaining, and handling of forms and records. (12 Dec 1998) |
| forms of DNA i, II and III | Refers to circular DNA removed from viruses and as plasmids. Form I is the DNA in its normal, supercoiled form. Form II is the DNA after one of the two strands has been nicked (cut apart), and is circular. Form III is the DNA after both strands have been broken, and is linear. (09 Oct 1997) |
| l forms | Bacterial variants, unable to form a complete cell wall, which are formed in cultures by various bacteria; granules (l bodies) appear, unite, and grow into amorphous bodies which multiply and give rise to bacterial cells morphologically indistinguishable from the parent strain. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|